首页> 外文期刊>Journal of Medicinal Chemistry >Synthesis and Biological Investigation of Oxazole Hydroxamates as Highly Selective Histone Deacetylase 6 (HDAC6) Inhibitors
【24h】

Synthesis and Biological Investigation of Oxazole Hydroxamates as Highly Selective Histone Deacetylase 6 (HDAC6) Inhibitors

机译:恶唑羟肟酸酯作为高选择性组蛋白脱乙酰基酶6(HDAC6)抑制剂的合成和生物学研究

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Histone deacetylase 6 (HDAC6) catalyzes the removal of an acetyl group from lysine residues of several nonhistone proteins. Here we report the preparation of thiazole-, oxazole-, and oxadiazole-containing biarylhydroxamic acids by a short synthetic procedure. We identified them as selective HDAC6 inhibitors by investigating the inhibition of B recombinant HDAC enzymes and the protein acetylation in cells by Western blotting (tubulin vs histone acetylation). The most active compounds exhibited nanomolar potency and high selectivity for HDAC6. For example, an oxazole hydroxamate inhibits HDAC6 with an IC50 of 59 nM and has a selectivity index of >200 against HDAC1 and HDAC8. This is the first report showing that the nature of a heterocycle directly connected to a zinc binding group (ZBG) can be used to modulate subtype selectivity and potency for HDAC6 inhibitors to such an extent. We rationalize the high potency and selectivity of the oxazoles by molecular modeling and docking.
机译:组蛋白脱乙酰基酶6(HDAC6)催化从几种非组蛋白的赖氨酸残基上去除乙酰基。在这里我们报告通过简短的合成程序制备噻唑,恶唑和恶二唑的联芳基异羟肟酸。我们通过研究B重组HDAC酶的抑制作用和通过蛋白质印迹法(微管蛋白与组蛋白乙酰化)在细胞中的蛋白乙酰化作用,将它们鉴定为选择性HDAC6抑制剂。最具活性的化合物对HDAC6表现出纳摩尔效价和高选择性。例如,恶唑异羟肟酸酯抑制HDAC6,IC50为59 nM,对HDAC1和HDAC8的选择性指数大于200。这是第一份报告,表明直接连接至锌结合基团(ZBG)的杂环的性质可用于在一定程度上调节HDAC6抑制剂的亚型选择性和效力。通过分子建模和对接,我们合理化了恶唑的高效性和选择性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号